Show Summary Details
Page of

Genetic Testing and Genomic Screening 

Genetic Testing and Genomic Screening
Genetic Testing and Genomic Screening

Angus John Clarke

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 October 2020

This chapter addresses the changes taking place in laboratory genetic investigations, the impact these are having on clinical practice and some of the difficult social, ethical and communication issues that arise as a consequence. In short, targeted genetic investigations are now being replaced by genomic (‘genome-wide’) investigations. This change is a process rather than an abrupt transformation and a role will persist for the more traditional technologies but the change is nonetheless real and progressive; it marks an important shift in clinical practice driven by changes in technology. The author emphasizes the impact of genomic screening on the practice of medicine and more broadly on society and the experience of ill health. Aspects of genetic and genomic screening outcome reporting are specifically addressed clarifying technical challenges of clinically relevant finding (pertinent finding), variant of unknown clinical significance and clinically relevant finding other than originally intended (incidental finding).

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.